Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.5.0.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Revenue:        
Product revenues $ 0 $ 0 $ 0 $ 0
License revenues 0 20,000 0 27,000
TOTAL REVENUE 0 20,000 0 27,000
Cost of Product Revenue 0 0 0 0
Gross profit 0 20,000 0 27,000
Operating Expenses:        
Research and development 250,000 0 475,000 250,000
Selling, general and administrative 1,871,000 1,451,000 5,547,000 3,019,000
Total operating expenses 2,121,000 1,451,000 6,022,000 3,269,000
Loss from Operations (2,121,000) (1,431,000) (6,022,000) (3,242,000)
Other income (expense)        
Change in value of warrant and derivative liabilities 5,263,000 29,140,000 36,759,000 17,874,000
Interest expense/income (1,599,000) (849,000) (3,245,000) (8,288,000)
Total Other Income (Expense) 3,664,000 28,291,000 33,514,000 9,586,000
Income before minority interest and provision for income taxes 1,543,000 26,860,000 27,492,000 6,344,000
Plus: net (income) loss attributable to the noncontrolling interests 0 0 0 0
Income before provision for income taxes 1,543,000 26,860,000 27,492,000 6,344,000
Provision for income taxes 0 0 0 0
Net income $ 1,543,000 $ 26,860,000 $ 27,492,000 $ 6,344,000
Income/(loss) per share - Basic $ 23,335,603 $ 2,396,381 $ 20,375,396 $ 2,389,080
Income/(loss) per share - Diluted $ 25,407,055 $ 4,907,238 $ 22,446,848 $ 4,899,898
Weighted Average Common Shares Outstanding - Basic 0.07 11.21 1.35 2.66
Weighted Average Common Shares Outstanding - Diluted 0.06 5.47 1.22 1.29